APN News

  • Monday, January, 2022| Today's Market | Current Time: 12:54:14
  • BioSig To Participate at Heart Rhythm Society’s Scientific Sessions 2019

    Published on April 30, 2019

    Santa Monica, CA : BioSig Technologies, Inc. , a medical device company developing a proprietary biomedical signal processing platform designed to address unmet needs for the electrophysiology (EP) marketplace, today announced that the Company will be exhibiting at the Heart Rhythm Society’s 40th Annual Scientific Sessions on May 8-11, 2019 at Moscone Center in San Francisco, CA.

     

    During the event BioSig will be presenting at booth 2056 in the South Hall of Moscone Center.

     

    Previously, BioSig announced that it successfully conducted its first patient cases using PURE EP(tm) System at the Texas Cardiac Arrhythmia Institute in Austin, TX in February 2019 and Greenville Memorial Hospital in Greenville, SC in April 2019. These initial experiences suggested improved cardiac signal detection and fidelity.

     

    The event will convene some of the finest clinicians, scientists, researchers and innovators in the field of cardiac pacing and electrophysiology. More than 800 of the world’s most noted experts in cardiac rhythm management are expected to serve as faculty for more than 200 educational sessions covering topic areas such as pacing, defibrillation, clinical arrhythmia management, ablation, pharmacology, genetics, basic science, health policy, and more.

     

    The PURE EP(tm) System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory. The PURE EP(tm) System aims to minimize noise and artifacts and acquire high-fidelity cardiac signals. Improving fidelity of acquired cardiac signals may potentially increase the diagnostic value of these signals, thereby possibly improving accuracy and efficiency of the EP studies and related procedures. The results of pre-clinical studies have been published in a number of journals, including The Journal of Innovations in Cardiac Rhythm Management and the Journal of the American College of Cardiology, a manuscript, which was included in the top 5 most read, discussed and shared articles in 2016.